新元科技(300472.SZ):首次授予限制性股票347.2萬股
格隆匯5月12日丨新元科技(300472.SZ)公佈,2020年5月11日,公司召開了會第三屆董事會第二十次會議、第三屆監事會第十四次會議,審議通過了《關於調整公司2020年限制性股票激勵計劃首次授予激勵對象名單及授予數量的議案》、《關於向公司2020年限制性股票激勵計劃激勵對象首次授予限制性股票的議案》,公司獨立董事對相關事項發表了獨立意見,監事會對此次授予限制性股票的激勵對象名單及授予安排等相關事項進行了核實。
根據《上市公司股權激勵管理辦法》以及此次激勵計劃的有關規定,公司董事會認為此次激勵計劃規定的首次授予條件均已滿足,確定首次授予日為2020年5月11日,限制性股票首次授予數量347.2萬股;限制性股票首次授予價格6.29元/股。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.